These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9864891)
41. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112 [TBL] [Abstract][Full Text] [Related]
42. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas. Querleu D; Dargent D; Ansquer Y; Leblanc E; Narducci F Cancer; 2000 Apr; 88(8):1883-91. PubMed ID: 10760766 [TBL] [Abstract][Full Text] [Related]
43. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Pieterse QD; Kenter GG; Gaarenstroom KN; Peters AA; Willems SM; Fleuren GJ; Trimbos JB Eur J Surg Oncol; 2007 Mar; 33(2):216-21. PubMed ID: 17097845 [TBL] [Abstract][Full Text] [Related]
44. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Morice P; Castaigne D; Pautier P; Rey A; Haie-Meder C; Leblanc M; Duvillard P Gynecol Oncol; 1999 Apr; 73(1):106-10. PubMed ID: 10094889 [TBL] [Abstract][Full Text] [Related]
45. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467 [TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408 [TBL] [Abstract][Full Text] [Related]
47. Where to look for the sentinel lymph node in cervical cancer. Bader AA; Winter R; Haas J; Tamussino KF Am J Obstet Gynecol; 2007 Dec; 197(6):678.e1-7. PubMed ID: 18060980 [TBL] [Abstract][Full Text] [Related]
48. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis. Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424 [TBL] [Abstract][Full Text] [Related]
49. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Sedlis A; Bundy BN; Rotman MZ; Lentz SS; Muderspach LI; Zaino RJ Gynecol Oncol; 1999 May; 73(2):177-83. PubMed ID: 10329031 [TBL] [Abstract][Full Text] [Related]
50. Is radical hysterectomy for early stage cervical cancer an outdated operation? Selman TJ; Luesley DM; Murphy DJ; Mann CH BJOG; 2005 Mar; 112(3):363-5. PubMed ID: 15713155 [TBL] [Abstract][Full Text] [Related]
51. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Di Stefano AB; Acquaviva G; Garozzo G; Barbic M; Cvjeticanin B; Meglic L; Kobal B; Rakar S Gynecol Oncol; 2005 Dec; 99(3):671-9. PubMed ID: 16129476 [TBL] [Abstract][Full Text] [Related]
52. Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer. Matsuo K; Grubbs BH; Mikami M J Gynecol Oncol; 2018 Jan; 29(1):e10. PubMed ID: 29185268 [No Abstract] [Full Text] [Related]
54. Difference in prognostic factors between stage IB and II uterine cervical carcinoma patients treated with radical hysterectomy and postoperative radiation therapy. Niibe Y; Karasawa K; Kaizu T; Mizutani K; Ozaki Y; Nagano H; Ueda K; Murakami A; Tanaka Y Radiat Med; 2002; 20(4):161-7. PubMed ID: 12296431 [TBL] [Abstract][Full Text] [Related]
55. Clinical study of sentinel lymph node biopsy in early uterine cervical carcinoma. Ying WH; Thakur B Kathmandu Univ Med J (KUMJ); 2005; 3(4):324-6. PubMed ID: 16449829 [TBL] [Abstract][Full Text] [Related]
56. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer. Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M J BUON; 2008; 13(1):51-4. PubMed ID: 18404786 [TBL] [Abstract][Full Text] [Related]
57. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432 [TBL] [Abstract][Full Text] [Related]
58. Surgical staging of gynecologic malignancies: the role of laparoscopy and sentinel node technology. Kim R; Rose PG Surg Oncol Clin N Am; 2005 Apr; 14(2):267-88. PubMed ID: 15817239 [No Abstract] [Full Text] [Related]
59. Sentinel lymph node identification in patients with early stage cervical cancer undergoing radical hysterectomy and pelvic lymphadenectomy. Li B; Zhang WH; Liu L; Wu LY; Zhang R; Li N Chin Med J (Engl); 2004 Jun; 117(6):867-70. PubMed ID: 15198889 [TBL] [Abstract][Full Text] [Related]